Doxycycline induces apoptosis and inhibits proliferation and invasion of human cervical carcinoma stem cells

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Yang, Binlie ^a   Lu, Yuping ^a   Zhang, Ai ^a   Zhou, Aizhi ^a   Zhang, Lei ^a   Zhang, Lanrong ^a   Gao, Limin ^a   Zang, Yuhua ^a   Tang, Xiuhua ^a   Sun, Liyan ^a  

^a Department of Gynecology and Obstetrics People Hospital of Pudong New Area   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ERROR; ANIMAL; APOPTOSIS; CANCER STEM CELL; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CONDITIONED MEDIUM; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; HUMAN; MOUSE; PATHOLOGY; TUMOR INVASION; UTERINE CERVICAL NEOPLASMS;

MUS;

CISPLATIN; CONDITIONED MEDIUM; DOXYCYCLINE;

ANIMALS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; CULTURE MEDIA, CONDITIONED; DOXYCYCLINE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84938300977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129138     Document Type: Article

References (33)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014; 64 (1):9-29. doi: 10.3322/caac.21208 PMID: 24399786.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians. 2012; 62 (1):10-29. doi: 10.3322/caac.20138 PMID: 22237781.
3. Organista-Nava J, Gomez-Gomez Y, Gariglio P. Embryonic stem cell-specific signature in cervical cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35(3):1727-38. doi: 10.1007/s13277-013-1321-y PMID: 24163107.
4. Charafe-Jauffret E, Ginestier C, Bertucci F, Cabaud O, Wicinski J, Finetti P, et al. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer research. 2013; 73(24):7290-300. doi: 10.1158/0008-5472.CAN-12-4704 PMID: 24142344.
5. Schieber MS, Chandel NS. ROS links glucose metabolism to breast cancer stem cell and EMT phenotype. Cancer cell. 2013; 23(3):265-7. doi: 10.1016/j.ccr.2013.02.021 PMID: 23518342.
6. Kim CF, Dirks PB. Cancer and stem cell biology: how tightly intertwined? Cell stem cell. 2008; 3 (2):147-50. doi: 10.1016/j.stem.2008.07.012 PMID: 18682238.
7. Wang Y, Armstrong SA. Cancer: inappropriate expression of stem cell programs? Cell stem cell. 2008; 2(4):297-9. doi: 10.1016/j.stem.2008.03.014 PMID: 18397746.
8. Gu W, Yeo E, McMillan N, Yu C. Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability. Cancer gene therapy. 2011; 18(12):897-905. doi: 10.1038/cgt.2011.58 PMID: 21904396.
9. Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell stem cell. 2014; 14(3):275-91. doi: 10. 1016/j.stem.2014.02.006 PMID: 24607403.
10. Yang ZJ, Wechsler-Reya RJ. Hit 'em where they live: targeting the cancer stem cell niche. Cancer cell. 2007; 11(1):3-5. doi: 10.1016/j.ccr.2006.12.007 PMID: 17222787.
11. Ababneh N, Alshaer W, Allozi O, Mahafzah A, El-Khateeb M, Hillaireau H, et al. In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker. Nucleic acid therapeutics. 2013; 23 (6):401-7. doi: 10.1089/nat.2013.0423 PMID: 24171482; PubMed Central PMCID: PMC3868357.
12. Cantile M, Collina F, D'Aiuto M, Rinaldo M, Pirozzi G, Borsellino C, et al. Nuclear localization of cancer stem cell marker CD133 in triple-negative breast cancer: a case report. Tumori. 2013; 99(5):e245-50. doi: 10.1700/1377.15325 PMID: 24362879.
13. Li H, Ma F, Wang H, Lin C, Fan Y, Zhang X, et al. Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer. The International journal of biological markers. 2013; 28(4):e357-64. doi: 10.5301/jbm.5000048 PMID: 24338721.
14. Wang K, Zeng J, Luo L, Yang J, Chen J, Li B, et al. Identification of a cancer stem cell-like side population in the HeLa human cervical carcinoma cell line. Oncology letters. 2013; 6(6):1673-80. doi: 10. 3892/ol.2013.1607 PMID: 24260061; PubMed Central PMCID: PMC3833864.
15. Wang Q, Liu H, Xiong H, Liu Z, Wang LE, Qian J, et al. Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer. Molecular carcinogenesis. 2013. doi: 10.1002/mc.22113 PMID: 24302553.
16. Wei XD, He J, Gao JX, Wang JY, Ma BJ, Chen J. [Investigation on biological characteristics of CD133+ cancer stem cells in human laryngeal carcinoma Hep-2 cell line]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery. 2013; 48(7):578-83. PMID: 24313208.
17. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proceedings of the National Academy of Sciences. 2009; 106(38):16281-6.
18. Chung SS, Aroh C, Vadgama JV. Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells. PloS one. 2013; 8(12):e83971. doi: 10.1371/journal.pone.0083971 PMID: 24386318; PubMed Central PMCID: PMC3875492.
19. Fuller J. Stem cell aging and cancer. Science of aging knowledge environment: SAGE KE. 2006; 2006 (9):pe12. Epub 2006/05/26. doi: 10.1126/sageke.2006.9.pe12 PMID: 16723637.
20. Mohseny AB, Machado I, Cai Y, Schaefer KL, Serra M, Hogendoorn PC, et al. Functional characterization of osteosarcoma cell lines provides representative models to study the human disease. Laboratory investigation; a journal of technical methods and pathology. 2011; 91(8):1195-205. Epub 2011/04/27. doi: 10.1038/labinvest.2011.72 PMID: 21519327.
21. Wright MH, Calcagno A, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. Brca1 breast tumors contain distinct CD44+/CD24-and CD133+ cells with cancer stem cell characteristics. Breast Cancer Research. 2008; 10(1):R10-R. doi: 10.1186/bcr1855 PMID: 18241344
22. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, et al. let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells. Cell. 2007; 131(6):1109-23. PMID: 18083101
23. Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2008; 26 (17):2839-45. Epub 2008/06/10. doi: 10.1200/JCO.2007.15.1829 PMID: 18539962; PubMed Central PMCID: PMC2739000.
24. Hadnagy A, Gaboury L, Beaulieu R, Balicki D. SP analysis may be used to identify cancer stem cell populations. Experimental Cell Research. 2006; 312(19):3701-10. PMID: 17046749
25. Uchida S, Yokoo S, Yanagi Y, Usui T, Yokota C, Mimura T, et al. Sphere formation and expression of neural proteins by human corneal stromal cells in vitro. Investigative ophthalmology & visual science. 2005; 46(5):1620-5. Epub 2005/04/27. doi: 10.1167/iovs.04-0288 PMID: 15851560.
26. Sagar J, Sales K, Seifalian A, Winslet M. Doxycycline in mitochondrial mediated pathway of apoptosis: a systematic review. Anti-cancer agents in medicinal chemistry. 2010; 10(7):556-63. PMID: 20879988.
27. Sekeroglu ZA, Afan F, Sekeroglu V. Genotoxic and cytotoxic effects of doxycycline in cultured human peripheral blood lymphocytes. Drug and chemical toxicology. 2012; 35(3):334-40. doi: 10.3109/01480545.2011.621954 PMID: 22289567.
28. Son K, Fujioka S, Iida T, Furukawa K, Fujita T, Yamada H, et al. Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells. Anticancer research. 2009; 29(10):3995-4003. PMID: 19846942.
29. Tang H, Sampath P, Yan X, Thorne SH. Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination. Gene therapy. 2013; 20(7):770-8. doi: 10.1038/gt.2012.96 PMID: 23282955; PubMed Central PMCID: PMC3620681.
30. Wu W, Yu LH, Ma B, Xu MJ. The inhibitory effect of doxycycline on cisplatin-sensitive and-resistant epithelial ovarian cancer. PloS one. 2014; 9(3):e89841. doi: 10.1371/journal.pone.0089841 PMID: 24598933; PubMed Central PMCID: PMC3943859.
31. Mouratidis PX, Colston KW, Dalgleish AG. Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells. International journal of cancer Journal international du cancer. 2007; 120(4):743-52. doi: 10.1002/ijc.22303 PMID: 17131308.
32. Sagar J, Sales K, Dijk S, Taanman J, Seifalian A, Winslet M. Does doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer? World journal of surgical oncology. 2009; 7:2. doi: 10.1186/1477-7819-7-2 PMID: 19126215; PubMed Central PMCID: PMC2628910.
33. Sun BC, Zhang SW, Qi LS, Zhang DF, Guo H, Zhao XL. [Effects of endostatin and doxycycline on microcirculation patterns in melanoma and their relevant molecular mechanisms]. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 2007; 29(7):500-4. PMID: 18069628.